Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
View of the world map with red markings indicating the latitudes and regions for which analyses of the dynamics of SARS-CoV-2 lines are available. SARS-CoV-2 viruses are symbolically distributed across the world map.

© CoVerage; CDC/Alissa Eckert, Dan Higgins

© CoVerage; CDC/Alissa Eckert, Dan Higgins
Jul 17 2025

Data-driven detection of concerning SARS-CoV-2 variants months in advance

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants

Logo of the European Vaccines Hub

European Vaccines Hub for Pandemic Readiness (EVH)

The European Vaccines Hub for Pandemic Readiness (EVH), a European consortium launched in 2025, aims to strengthen the long…

A close-up image of a healthcare professional wearing white gloves administering a vaccine injection into a person's upper arm using a syringe.

© Mufid Majnun auf Unsplash

© Mufid Majnun auf Unsplash
Jul 24 2025

Therapeutic vaccine for chronic hepatitis B enters first clinical trial in patients

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich in collaboration with the German Center for Infection Research (DZIF), has entered its

Jan 2025
Trends Parasitol

Genetically attenuated parasites show promise as a next-generation malaria vaccine

Autoren
Hafalla JCR
Borrmann S
Matuschewski K
Feb 2025
Nat Commun

Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen

Autoren
Chih YC et al.
Jan 2025
Open Forum Infect Dis

BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Autoren
Carrero Longlax S et al.
Feb 2025
VACCINE X

Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts

Autoren
Siebner AS et al.
Jan 2025
Implement Sci

Optimizing vaccine uptake in sub-Saharan Africa: a collaborative COVID-19 vaccination campaign in Madagascar using an adaptive approach

Autoren
Pavoncello V et al.
Feb 2025
Inn Med (Heidelb)

[Real world data show effectiveness of new respiratory syncytial virus (RSV) vaccines]

Autoren
Matt U
Nitschmann S
Herold S
Feb 2025
J Travel Med

TravVacNet-Group. First clinical experiences with the tetravalent live vaccine against dengue (Qdenga®) in travellers: a multicentric TravVacNet study in Germany

Autoren
Köpke C et al.

Pagination

< Zurück
Current page 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states